Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors-retrospective study.
Higaki H, Nishioka K, Otsuka M, Nishikawa N, Shido M, Minatogawa H, Nishikawa Y, Takashina R, Hashimoto T, Katoh N, Taguchi H, Kinoshita R, Yasuda K, Mori T, Uchinami Y, Koizumi F, Fujita Y, Takahashi S, Hattori T, Nishiyama N, Aoyama H.
Higaki H, et al. Among authors: koizumi f.
Radiat Oncol. 2023 Feb 7;18(1):25. doi: 10.1186/s13014-023-02218-3.
Radiat Oncol. 2023.
PMID: 36750899
Free PMC article.